<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HA5A81DC6A56F4945ADBDF2A9B83711ED" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 2459 IH: Delivering Antimicrobial Transparency in Animals Act of 2015</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-05-19</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress> <session>1st Session</session> 
<legis-num>H. R. 2459</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150519">May 19, 2015</action-date> 
<action-desc><sponsor name-id="S000480">Ms. Slaughter</sponsor> (for herself, <cosponsor name-id="L000582">Mr. Ted Lieu of California</cosponsor>, <cosponsor name-id="R000053">Mr. Rangel</cosponsor>, and <cosponsor name-id="S001145">Ms. Schakowsky</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc> 
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Federal Food, Drug, and Cosmetic Act to enhance the reporting requirements pertaining to use of antimicrobial drugs in food animals.</official-title> 
</form> 
<legis-body id="HF9752FE1780E410D9E298B8A38E6AED2" style="OLC"> 
<section id="H2A1FE3BE080A491DBEBABE39F52FE46B" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Delivering Antimicrobial Transparency in Animals Act of 2015</short-title></quote>.</text></section> <section id="H1A9611BC2F8F4D44AC153A4271539564"><enum>2.</enum><header>Purpose</header><text display-inline="no-display-inline">The purpose of this Act is to provide the Food and Drug Administration and the public with better information on the use of antimicrobial drugs in animals used for food to—</text> 
<paragraph id="H2C763E78DCC2449AB12FAEE94748A594"><enum>(1)</enum><text>enable public health officials and scientists to better understand and interpret trends and variations in rates of microbial resistance to such antimicrobial drugs;</text></paragraph> <paragraph id="H31E86324788046CAAD5D3ADC3F8280CC"><enum>(2)</enum><text display-inline="yes-display-inline">improve the understanding of the relationship between antimicrobial drug use in animals used for food and antimicrobial drug resistance in microbes in and on animals and humans; and</text></paragraph> 
<paragraph id="H355ED329CA5A429DA0472D8BF2AD06B1"><enum>(3)</enum><text display-inline="yes-display-inline">identify interventions to prevent and control such antimicrobial drug resistance.</text></paragraph></section> <section id="H43D3E75E614F43AB914937035DCB3108"><enum>3.</enum><header>Enhanced reporting requirements</header> <subsection id="H63A56FBB9BF447B9BBCF07448621D654"><enum>(a)</enum><header>Reports</header><text>Section 512(l) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360b">21 U.S.C. 360b(l)</external-xref>) is amended by striking paragraph (3) and inserting the following:</text> 
<quoted-block display-inline="no-display-inline" id="H2666D2B9DBB44503B84E9B47663E76B7" style="OLC"> 
<paragraph id="H668DB02B26D14878AD716F0A6011AB0B"><enum>(3)</enum> 
<subparagraph commented="no" display-inline="yes-display-inline" id="HD390E6F17DEB424A96F030006BC4BF18"><enum>(A)</enum><text>In the case of each new animal drug described in paragraph (1) that contains an antimicrobial active ingredient, the sponsor of the drug shall submit an annual report to the Secretary on the amount of each antimicrobial active ingredient in the drug that is sold or distributed for use in food-producing animals, including information on any distributor-labeled product.</text></subparagraph> <subparagraph id="HCFFA4FB43AD34E0AB94BF88290707B55" indent="up1"><enum>(B)</enum><text>Each report under this paragraph shall specify the amount of each antimicrobial active ingredient—</text> 
<clause id="H211D3A94496049959CA3C91E26D0445C"><enum>(i)</enum><text>by container size, strength, and dosage form;</text></clause> <clause id="H6FB58F96D51C4263BEC80BAC648C0D2E"><enum>(ii)</enum><text>by quantities distributed to each State domestically and by quantities exported; and</text></clause> 
<clause id="HCA372074070B45CEA51B34249154BB2B"><enum>(iii)</enum><text display-inline="yes-display-inline">by dosage form, including (for each dosage form) the known or estimated amounts of the antimicrobial active ingredient sold or distributed for use in each food-producing animal for which the new animal drug is approved, including a description of the methods used to determine or estimate the amounts.</text></clause></subparagraph></paragraph> <paragraph id="HE1115A79B1974BA69C9D34CCF3E82327"><enum>(4)</enum> <subparagraph commented="no" display-inline="yes-display-inline" id="H3BC7B22CD43545CE994AD23EC9805C30"><enum>(A)</enum><text display-inline="yes-display-inline">Subject to subparagraph (B), in the case of animal feed in final formulation bearing or containing a new animal drug for which reporting is required under paragraph (3), a live poultry dealer, swine contractor, or feed lot operator who purchases, contracts, or manufactures such feed shall submit to the Secretary an annual report that specifies, by food-producing animal for which the new animal drug is approved and, where applicable as determined by the Secretary, by production class of such animal—</text> 
<clause id="H495665E725DB4007B05BCF81D85F323B" indent="up1"><enum>(i)</enum><text>the amount of each antimicrobial active ingredient contained per kilogram of each such feed sold or distributed for that animal and, where applicable, production class;</text></clause> <clause id="HAE15306CDCA541DF83B87CD5E70618C7" indent="up1"><enum>(ii)</enum><text>the quantity of such feed sold or distributed for that animal and, where applicable, production class; and</text></clause> 
<clause id="H4F32E71F4B484139940DA535C049B2C2" indent="up1"><enum>(iii)</enum><text>for each such feed sold or distributed under a veterinary feed directive—</text> <subclause id="H2A21CFFAD3784D93A685F6BD3335EE3B"><enum>(I)</enum><text>the indications for which the feed was sold or distributed and the quantities of such feed that were sold or distributed per each such indication;</text></subclause> 
<subclause id="H4DB4B8891AA1480BA46779DFCF4D157D"><enum>(II)</enum><text>the number of individuals of the food-producing animal and, where applicable, the production class to which the feed was intended; and</text></subclause> <subclause id="H95BF357B8EF744699E8B64FDAB745376"><enum>(III)</enum><text>the length of time over which the feed was intended to be provided to the animals and the dose of the active antimicrobial ingredient the animals were intended to receive.</text></subclause></clause></subparagraph> 
<subparagraph id="H25A4685AA4C44E7089847A52C053C27E" indent="up1"><enum>(B)</enum> 
<clause commented="no" display-inline="yes-display-inline" id="HB2F7A2D476854878AD430F4FA5FBE4EA"><enum>(i)</enum><text>Subparagraph (A) does not apply to a live poultry dealer, swine contractor, or feed lot operator if the total value of the live animals owned, purchased, sold, contracted for, or otherwise controlled by the dealer, contractor, or operator, directly or through subsidiaries or affiliates, per year, does not exceed—</text> <subclause id="H3B30C7163AED4B0394EF9A6B0510C908" indent="up1"><enum>(I)</enum><text>$10,000,000; or</text></subclause> 
<subclause id="H84875C14A91D4AAA9FEE96550C7AFE67" indent="up1"><enum>(II)</enum><text>such other sum as the Secretary may specify through regulation.</text></subclause></clause> <clause commented="no" id="H74CEA27DC9B741C4BE28219070188540" indent="up1"><enum>(ii)</enum><text>The Secretary may specify through regulation alternative reporting requirements, including via pilot programs or based on the results of pilot programs—</text> 
<subclause id="H7AB00D5AD66348998E6A81FF1B38BB71"><enum>(I)</enum><text>to improve the accuracy of reports;</text></subclause> <subclause id="H98F0898955004634A10429C4AF57D346"><enum>(II)</enum><text>to lessen the burden of reporting;</text></subclause> 
<subclause id="H5075076229BA4877AFE2DDBF810147C7"><enum>(III)</enum><text>to facilitate the Secretary’s ability to provide public summaries of the reports; or</text></subclause> <subclause id="H98EB21062D414BBABD5668B23947E24C"><enum>(IV)</enum><text>to improve the Secretary’s ability to use the reports, or the public’s ability to use the summaries under paragraph (5), to understand the relationship between sales, distribution, and end-use practices with respect to feed containing new animal drugs described in paragraph (1) and antimicrobial resistance trends in microbes in animals, animal food products, and humans.</text></subclause></clause></subparagraph></paragraph> 
<paragraph id="H6104D417095047798352F310F2286EA7"><enum>(5)</enum> 
<subparagraph commented="no" display-inline="yes-display-inline" id="H0731D126F91E412C95A33AEA63914E5F"><enum>(A)</enum><text>Each report under paragraph (3) or (4) shall—</text> <clause id="H2CA9A95469D94AAF8756744E3E2DB3D7" indent="up1"><enum>(i)</enum><text>be submitted electronically not later than March 31 each year;</text></clause> 
<clause id="H5A90DC537FA347F8B06396889D811B87" indent="up1"><enum>(ii)</enum><text>cover the period of the preceding calendar year;</text></clause> <clause id="HC98DCFC67524455BA4268E7C297E912B" indent="up1"><enum>(iii)</enum><text>include separate information for each month of such calendar year; and</text></clause> 
<clause id="H58399FFB9A854F6BBB8AE3F5B2E983AB" indent="up1"><enum>(iv)</enum><text>be in such format as the Secretary may require.</text></clause></subparagraph> <subparagraph id="HD98B8713EE26436F9609EC682DA3CEB2" indent="up1"><enum>(B)</enum><text>In specifying a format under subparagraph (A)(iv), the Secretary shall seek to ensure that such format enables the data reported to be integrated or otherwise easily associated and compared with data from other Federal databases containing data on—</text> 
<clause id="H7518643DDA654832A8B8F86649EFC57A"><enum>(i)</enum><text>drug sales for human use; and</text></clause> <clause id="H21910E1DA0B9479EBA99C04258EEF58B"><enum>(ii)</enum><text>rates of antimicrobial resistance in bacteria in and on animals, animal food products, and people.</text></clause></subparagraph> 
<subparagraph id="HEBC2D9D487B940C9A0DCF9EA7F8D9138" indent="up1"><enum>(C)</enum><text>The Secretary may share information reported under paragraph (3) or (4) with the Antimicrobial Resistance Task Force established under section 319E of the Public Health Service Act.</text></subparagraph> <subparagraph id="HF579F020C7E8492CB6EB5E693759B734" indent="up1"><enum>(D)</enum> <clause commented="no" display-inline="yes-display-inline" id="HAFD8AAB70EA4478381312BC8A121FBAD"><enum>(i)</enum><text>Not later than November 30 each year, the Secretary shall make publicly available summaries of the information reported under paragraphs (3) and (4).</text></clause> 
<clause id="HBC03AAC8E15F43DB9625C9EBBB393C08" indent="up1"><enum>(ii)</enum><text>For each summary under clause (i), except as provided in clause (iii), the Secretary shall—</text> <subclause id="HB8E3F11D44464E39AD8969F9BE9A0241"><enum>(I)</enum><text>report data by antimicrobial drug class;</text></subclause> 
<subclause id="H51B235967A3B4B9494F60B192B8575B7"><enum>(II)</enum><text display-inline="yes-display-inline">for each such antimicrobial drug class, specify—</text> <item id="HCF04B9F9A0B347168446399A6BB0B124"><enum>(aa)</enum><text>the quantity of drugs sold or distributed per dosage form;</text></item> 
<item id="H54912061C1444309BB8B2023088FFA89"><enum>(bb)</enum><text>the percentage of drugs sold or distributed with labeled indications that fall within each of the following categories: growth promotion, feed efficiency, or other production purposes; disease prevention; disease control; and disease treatment;</text></item> <item id="HE63708273A17481F9153641B8EDF2829"><enum>(cc)</enum><text>the quantity of drugs sold or distributed per each of the following marketing categories: over-the-counter, prescription, and veterinary feed directive;</text></item> 
<item id="HB81438201D284E3BAFA0E6A1A12E2236"><enum>(dd)</enum><text>the quantity of drugs sold or distributed per State of sale or distribution; and</text></item> <item id="H079F7891C7314322A8288821E4C30B11"><enum>(ee)</enum><text display-inline="yes-display-inline">the known or estimated quantity of drugs sold or distributed for each food-producing animal and, where feasible, production class of such animal; and</text></item></subclause> 
<subclause id="H0CB5DB2F10FB4B429EB92DEF5D80694D"><enum>(III)</enum><text>for each feed sold or distributed under a veterinary food directive for which reporting is required under paragraph (4), include the information reported pursuant to subclauses (I), (II), and (III) of paragraph (4)(A)(iii).</text></subclause></clause> <clause id="H3F8FABE852FC46E3B04F8B105E89CC21" indent="up1"><enum>(iii)</enum><text>For any antimicrobial drug class with fewer than 3 sponsors of approved new animal drugs, instead of reporting data under clause (ii), the Secretary shall for each such class—</text> 
<subclause id="H7DB717E69F2A4BD4BE5D348E6130D687"><enum>(I)</enum><text>report data by category of importance of the antimicrobial drugs within that class to human medicine, as determined by the Secretary; and</text></subclause> <subclause id="HBE1F9EF3B8C844899B2DFF21A3DFC1AE"><enum>(II)</enum><text display-inline="yes-display-inline">to the extent feasible for each such category, specify—</text> 
<item id="H4CE15A2812F3443D8ED614CB2516B0C7"><enum>(aa)</enum><text>the quantity of drugs sold or distributed per dosage form;</text></item> <item id="H0EE4572ECA784B758DA7A67CEF486553"><enum>(bb)</enum><text>the percentage of drugs sold or distributed with labeled indications that fall within each of the following categories: growth promotion, feed efficiency, or other production purposes; disease prevention; disease control; and disease treatment;</text></item> 
<item id="H0D8DC617B07240B681D1F31690F865A1"><enum>(cc)</enum><text>the quantity of drugs sold or distributed per each of the following marketing categories: over-the-counter, prescription, and veterinary feed directive; and</text></item> <item id="HA83643B3D67F4663AA33430A4F86DDBD"><enum>(dd)</enum><text>the quantity of drugs sold or distributed per State of sale or distribution.</text></item></subclause></clause> 
<clause id="H29C4574DAE914BD38A36B12FCE822EFC" indent="up1"><enum>(iv)</enum><text>In carrying out this subparagraph, the Secretary shall report data in a manner consistent with protecting both national security and confidential business information.</text></clause></subparagraph> <subparagraph id="HBEE4E38BBEB74423B56FE00D0A384960" indent="up1"><enum>(E)</enum><text>In this paragraph, the terms <term>live poultry dealer</term> and <term>swine contractor</term> have the meanings given to those terms in section 2 of the Packers and Stockyards Act, 1921.</text></subparagraph></paragraph><after-quoted-block>.</after-quoted-block></quoted-block></subsection> 
<subsection id="H73E4CF49FD5F4A73BA34901D06599814"><enum>(b)</enum><header>Rule of application</header><text display-inline="yes-display-inline">The amendment made by this section applies to reports under paragraphs (3) and (4) of section 512(l) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360b">21 U.S.C. 360b(l)</external-xref>) (as amended by subsection (a)) that cover the period of the first calendar year beginning after the date of enactment of this Act or any subsequent calendar year. The provisions of section 512(l)(3) of such Act, as in effect the day before the date of enactment of this Act, apply to reports that cover the period of any calendar year beginning before the calendar years described in the preceding sentence.</text></subsection></section> <section id="HCA0796F9A0E046038AB1DAF5425AF857"><enum>4.</enum><header>Enhanced collaboration between the Food and Drug Administration and the Department of Agriculture</header><text display-inline="no-display-inline">The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall increase collaboration and coordination with the Secretary of Agriculture to expand and coordinate the collection of data on the use of antimicrobial drugs in or on cattle, swine, chickens, turkeys, and such other food-producing animal species as agreed to by the Secretary of Health and Human Services and the Secretary of Agriculture, including by providing information to the Secretary of Agriculture for use by—</text> 
<paragraph id="HC98447156B694D4286B7B318A9F3D0E4"><enum>(1)</enum><text>the Animal and Plant Health Inspection Service to help inform its collection of data through the National Animal Health Monitoring System; and</text></paragraph> <paragraph id="H22B74CE3619748C0A6A9F7CE4814A9CE"><enum>(2)</enum><text display-inline="yes-display-inline">the Economic Research Service to help inform its collection of data through the Agricultural Resource Management Survey.</text></paragraph></section> 
<section id="HDF90595D61AD4B5180F5651DD0255AB1"><enum>5.</enum><header>Report by GAO</header> 
<subsection id="HED6D7DB3B4EB4AFFB7B389F6CC3870C0"><enum>(a)</enum><header>In general</header><text>Not later than 3 years after the date of enactment of this Act, the Comptroller General of the United States shall commence a study to evaluate—</text> <paragraph id="H52849DD6E4AB492EBA09669C3E646E65"><enum>(1)</enum><text>the voluntary approach used by the Food and Drug Administration to eliminate injudicious use of antimicrobial drugs in food-producing animals; and</text></paragraph> 
<paragraph id="HBF4AFCF3A3364203832896417B24E22E"><enum>(2)</enum><text>the effectiveness of the data collection activities conducted by the Food and Drug Administration regarding antimicrobial resistance.</text></paragraph></subsection> <subsection id="H3AB560C92A1C49CD973A25353EC078E1"><enum>(b)</enum><header>Report</header><text>Not later than 1 year after commencing the study required by subsection (a), the Comptroller General of the United States shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report that describes the results of such study.</text></subsection></section> 
</legis-body> 
</bill> 


